Author

Camilla K. Larsen

Novo Nordisk (Denmark)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Synthetic Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Organism:E. coli· 1 Approach:experimental assay· 1 Research Focus:protein design· 1 Research Focus:protein structure prediction· 1 Assay:proteomics· 1

Frequent Co-Authors

Alice R. MadseniD· 1 shared Anne Louise Bank KodaliD· 1 shared Kim F. HaselmanniD· 1 shared Kjeld Olesen· 1 shared METTE MARIE ROSENKILDEiD· 1 shared Peter LindquistiD· 1 shared Thomas TørringiD· 1 shared Tine GlendorfiD· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperSynthetic Biology

Alice R. MadsenORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Using LanM Enzymes to Modify Glucagon-Like Peptides 1 and 2 in E.coli

Camilla K. Larsen, Peter Lindquist, METTE MARIE ROSENKILDE, Alice R. Madsen, Kim F. Haselmann, Tine Glendorf, Kjeld Olesen, Anne Louise Bank Kodal, Thomas Tørring

The paper uses LanM enzymes and leader peptides to modify D-Ala in GLP-1 and GLP-2 in E. coli, showing how precursor design affects modification patterns.

bioRxiv · Mar 20, 2023 · PreprintSynthetic Biology